Live Breaking News & Updates on Viatris Biosimilars
Stay updated with breaking news from Viatris biosimilars. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company said the revenue growth was supported by income from the divesture of two non-core business assets of Biocon Biologics branded formulations India business amounting to Rs 350 crore and a gain of Rs 456 crore from Biocons stake dilution in Bicara Therapeutics. ....
nikkei.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nikkei.com Daily Mail and Mail on Sunday newspapers.
She said the deal will enable BBL to attain a robust commercial engine in the developed markets of U.S. & Europe and will fast-track the company s journey of building a strong global brand. Biocon Biologics to Acquire Viatris Biosimilars Assets for Up to USD 3.335 Billion in Stock and Cash. ....